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BACKGROUND: The depletion of glucose transporter 4 (GLUT-4)  affects blood glucose level in the type 2 diabetes mellitus (T2DM) patient. 
Herbals supplementation such as Artemisia annua is known 
to  posses  an  antidiabetic  potency,  but  its  effect on 
long term glucose control marker, glicated hemoglobin 
(HbA1C) and muscle GLUT-4 expression still has not been 
investigated.
METHODS: Twenty Wistar rats were divided into four 
groups (five rats per group). The C1 group was consist of 
healthy control rats and C2 group was consist of diabetic 
control rats. Diabetic condition was induced by giving 
high lard fat diet for 28 days, followed with 30 mg/kgBW 
of Streptozotocin  injection  at the 29th day. Meanwhile, 
T1 and T2 group were consist of diabetic rats, which 
were supplemented with 50 mg/kgBW and 100 mg/kgBW 
of Artemisia annua leaf extract, respectively. GLUT-4 
expression and HbA1C level were measured at the 14th day 
post-treatment.  
RESULTS: The GLUT-4 was expressed 1.8 and two 
times higher in T1 and T2 group, respectively, compared 
to C2 group. Meanwhile, HbA1C level in C2 group was 
two times higher than C1 group (11.95±2.52 compared to 
5.61±2.69, p<0.01). Further, the administration of 100 mg/
kgBW Artemisia annua extract caused a slight reduction of 
HbA1C (11.95±2.52 compared to 8.18±3.53, p>0.05) 
CONCLUSION: Muscle cell’s GLUT-4 in T1 and T2 
group was expressed increasingly and significantly different 
compared to the C2 group. HbA1C level in T2 was slightly 
reduced although no significant different compared to C2 
group. 
KEywORDS: Artemisia annua, GLUT-4, HbA1C, type 2 
diabetes mellitus
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Abstract
Introduction
Type 2 diabetes mellitus (T2DM) is a condition, which 
insulin is unable to bind the receptor on dependent-insulin-
cells of liver, muscle and adipose. In 2010, there are more 
than 300 milion DM prevalence, and it is predicted to be 
double in 2030.(1) 
 Under the T2DM condition, there are several process 
in alteration glucose transporter 4 (GLUT-4) formation. 
GLUT-4 is a special transporter located mostly in striated 
muscle. This transporter facilitates glucose influx and 
utilization. Long term high fat diet increases radical oxidant 
and inflammation that induces glucolipotoxicity and islet 
cell apoptosis. This condition decreases insulin secretion 
and reduces signaling pathway of GLUT-4 formations. 
Reduced activities of GLUT-4 signaling pathway interferes 
with pheripheral glucose utilization and affects blood-
glucose control which marked by high level of glicated 
haemoglobin (HbA1C). In further condition, uncontrolled 
long term blood glucose will increase the complication of 
chronic T2DM and organs failure.(2,3)
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 The complexity of T2DM pathogenesis, encourage 
researcher to invent and develop new drugs research. 
The new drug is expected to be able to improve GLUT-4 
function, so, it can maintain long term glucose control  that 
caused by high fat intake and insulin resistance. Nowadays, 
World Health Organization (WHO) promotes research to 
investigate new T2DM drugs from natural herbs because of 
their multiple target therapy and safeties.(4-6) 
 Artemisia annua was previously used as antimalarial, 
however it also proven to have antidiabetic potency. 
Previous research documented that an administration of 
28.5 mg/kgBW twice/day Artemisia annua leaf extract 
for 2 weeks on alloxan-induced rats, reduces fasting blood 
glucose (FBG), increases insulin production and decreases 
homeostasis model assessment for insulin resistance 
(HOMA-IR).(7) The purified extract of 83.56 mg/kgBW of 
Artemisia annua is better for lowering FBG.(8) Artemisia 
annua contains squiterpen, coumarin and flavonoids, 
which have multi-target therapy as antidiabetic. However, 
more information related to the expression of GLUT-4 in 
muscle tissue and HbA1C mediating high fat diet needs to 
be carried out. Hence, this research is aimed to prove the 
effect of Artemisia annua leaf extract on muscle GLUT-4 
expression and HbA1C level in T2DM caused by high fat 
diet condition.
Methods
This was an experimental post test control only study that 
was conducted in Universitas Gadjah Mada for three months. 
Ethical approval was obtained from Medical Research Ethic 
Committee Universitas Diponnegoro-Kariadi Hospital, 
Number 967/EC/FK RSDK/IX/2016.
Experimental Protocol (Animal Treatment)
Twenty 6-8 weeks-old-male Wistar rats weighed 150-
200 grams was obtained from Center of Inter-University 
Laboratory of Universitas Gadjah Mada. The rats were 
divided into four groups, which each group consist of five 
rats. Every single rats were placed individually in separated 
cages. They were housed under normal room temperature 
25±2oC, 50±12%  of humidity and 12 hours of photoperiod 
cycles. Each cages were provided with standard diet and 
water ad libitum.
 The groups consist of healthy control group (C1 group) 
which was given standard diet, and diabetic control group 
(C2 group)  that  was  administered  with  placebo. Then, 
diabetic treatment groups which supplemented with 50 mg/
kgBW of Artemisia annua leaf extract (T1 group) and 100 
mg/kgBW of Artemisia annua leaf extract (T2 group).  
T2DM Induction
Diabetic rats (C2, T1 and T2 group) were induced using 
lard 20% of rats’ total calory diet for about 28 days, 
through intragastric sonde, followed by 30 mg/kgBW 
of streptozotocyn that were injected intraperitoneally.
(9) T2DM condition was determined by FBG level (more 
than 140 mg/dL at 36th day).(9) Treatment group were 
supplemented with Artemisia annua leaf extract at dose 50 
mg/kgBW and dose 100 mg/kgBW for 14 days treatment 
after streptozotocyn treatment (day 36 until day 50). 
Artemisia annua leaf extract was given orally to gastric, to 
avoid drug-food interaction.(10) 
Extract Preparation
Artemisia annua extract was made from five kg of the plant's 
leaf. The leaf was dried at 40oC using oven for three days. 
About 100 gr dried leaves was grinded until they became 
powder, then boiled in 1 L of sterriled water at 60oC for 
30 minutes. The extract was cooled at room temperature 
and filtered using Whatman® quantitative filter paper, 
ashless, Grade 41 (Merck, Darmstadt, Germany). The liquid 
concentrate extract was heated in cabinet dryer at 40oC for 
an hour.(11) The final extract obtained was as much as 16.4 
gr. Spectrophotometry analysis was conducted to measure 
the wavelength of extract and to determine the contained 
compound.  
Muscle GLUT-4 and HbA1c Analysis
Blood collection was conducted at the 50th day using 
hematocrit from plexus retroorbita. Collected blood was 
placed in the 2 mL sterile ethylenediaminetetraacetic 
acid (EDTA) tube. After that, all rats were sacrificed, 
and the gastrocnemous muscle were collected for 
immunohistochemistry analysis of GLUT-4 expression. The 
GLUT-4 expression scale was examined based on Allred 
scoring that observed by Anatomy Pathologist expert, 
microscopically. The Anatomy Pathologist examined five 
field areas using 400x magnificence lens and then scored to 
analyze. Collected blood was centrifuged at 8000 RPM for 
eight minutes to separate blood composition. The plasma 
was used to measure HbA1C by high performance layer 
chromatography. (12) 
 The GLUT-4 Allred score and HbA1C level were 
analyzed statistically using one way ANOVA, followed by 
fisher exact Least Significant Difference (LSD) using SPSS 
21 for windows.
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The extraction yielded 16.9 gram of paste extract. Artemisia 
annua leaf extract was measured using spectrophotometry 
wavelength >310 nm and >270 nm for band I and II. 
After measurement, the extract indicated that it contained 
flavonoid compound inside.
Blood Glucose during Fasting and Post Prondial
After streptozotocyn injection, FBG level in diabetic rats 
(C2, T1 and T2) was increased beyond the FGB level of 
C1 group. The highest FBG concentration was measured 
in T2 group (195.26±3.58 mg/dL) followed by T1 group, 
(193.66±2.19 mg/dL), and lastly was C2 group eventhough 
was not significantly different (191.08±2.29 mg/dL). Based 
on those conditions, all rats in diabetic induction have FBG 
concentration more than 140 mg/dL, which indicating 
a succesfull diabetic induction. T1 and T2 groups were 
administrated with Artemisia annua leaf extract for 14 days, 
then the FGB concentration was remeasured to determine 
the blood glucose condition. Based on the analysis, there 
were lowered blood glucose in all diabetic rats. The highest 
depression in T2 group, which was 44.6% to 108.20±2.62 
mg/dL. It was significantly different to T1 group with 32.32% 
depression and 131.50±2.62 mg/dL level of blood glucose. 
Meanwhile, blood glucose in C2 group was depressed as 
much as 0.3%, to 191.72±2.29 mg/dL (Table  1). 
 On the other hand, post prandial blood glucose that 
represent the glucose concentration that circulated in 
periferal blood stream (glucose in blood vessel) in diabetic 
group increased beyond normal level (Table 2). After 100 
mg/kgBW of Artemisia annua leaf extract administration, 
the post prandial blood glucose sharply went down in T2 
group up to 45.5% from 204.98±3.15  mg/dL to 111.94±2.41 
mg/dL. It was significantly different to other groups (C1, 
Results
Group
Before Induction 
(BI) (mg/dL)*
Post Induction 
(PI) (mg/dL)
Post Treatment 
 (PT) (mg/dL) (PT-PI) (%)
C1 59.91±1.01 61.68±1.08a 62.93±1.19a 1 ↑
C2 57.26±1.83 191.08±2.29b 191.72±2.29b 0.3 ↑
T1 56.66±2.15 193.66±2.19bc 131.50±2.62c 32.12 ↓
T2 56.41±1.78 195.26±3.58c 108.20±2.62d 44.6 ↓
Table 1. FBG level in T2DM rats before induction, post induction and post 
treatment conditon.
*no significant different; alphabetic labels (a-d) represent significant differencies of 
mean value among each groups.
C2 and T1). In T1 group, the blood glucose decreased as 
much as 34.3% from 204.58±2.24 mg/dL to 134.73±2.01 
mg/dL. But, both in T1 and T2 were decresed higher than 
C1 (0.08%) and C2 (2.9 %) (Table 2).
Effect of Artemisia annua Extract to HbA1C
HbA1C level gives better understanding about long term 
blood glucose control in diabetic condition. The HbA1C 
in C2 group was 11.95±2.52 mg/dL, it was higher and 
significantly different compared to C1 group, 5.61±2.69 
mg/dL (p<0.01). Furthermore, administration of 100 mg/
kgBW of Artemisia annual extract in T2 group slightly 
reduced HbA1C level at 8.18±3.53 mg/dL, although it is not 
significantly different with C2 group. Administration of 50 
mg/kgBW can not reserve diabetic codition (HbA1C level = 
11.16±2.52) (Figure 1). 
Effect of Artemisia annua  to GLUT-4 Protein Expression 
in The Muscle
To understand the mechanism underlying the ability 
of Artemisia annua extract to reverse T2DM state, we 
examined the muscle GLUT-4 expression post extract 
treatment (Figure 2). DM rats experienced 50% reduction 
in the muscle GLUT-4 expression, which was confirming 
the T2DM state that previously confirmed in the HbA1c 
studies. The administration of Artemisia annua extract 
for 14 days increased muscle GLUT-4 expression by 1.8 
and two fold by using 50 mg/kgBW and 100 mg/kgBW, 
respectively. Interestingly, the level of GLUT-4 expression 
after 100 mg/kgBW administration of the extract reversed 
the GLUT-4 expression into normal level as we did not 
see significant difference of GLUT-4 expression between 
healthy and diabetic rats treated with 100 mg/kg BW 
extract.  Furthermore,  there  was  a  trend  of  concentration 
dependent on the ability of the extract improving the GLUT-
4 expression.
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Group
Before Induction 
(BI) (mg/dL)*
Post Induction 
(PI) (mg/dL)
Post Treatment 
(PT) (mg/dL) (PT-PI) (%)
C1 65.91±1.17 67.87±1.63a 67.30±0.81a 0.08 ↓
C2 62.82±2.17 201.04±2.81b 195.02±2.09b 2.9 ↓
T1 62.65±2.64 204.58±2.24b 134.73±2.01c 34.3 ↓
T2 62.65±1.37 204.98±3.15b 111.94±2.41d 45.5 ↓
Table 2.  Post prandial blood glucose level in T2DM rats before induction, post 
induction and post treatment conditon.
*no significant different; alphabetic labels (a-d) represent significant differencies of 
mean value among groups.
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Figure 1. The level of HbA1C in DM rats post treatment. 
Rats were treated with Artemisia annua leaf extract after 14 days. 
*p<0.05; **p<0.0001; n.s.: not significant. 
Figure 2. Muscle GLUT-4 expression examined using 
immunohistochemistry post treatment. Artemisia annua leaf 
extract reverse the depletion of GLUT-4 in the diabetic condition as 
there is an increased in GLUT-4 expression. *p<0.05;***p<0.0001; 
n.s.: not significant. 
Discussion
In this research, the administration of high lard fat diet 
followed by streptozotocin injection increased the blood 
glucose and represented T2DM condition. High fat diet will 
induced peripheral insulin resistance, by activating kinase 
protein C (PKC) and fight the function of insulin receptor 
substrate (IRS).(13,14) Low dose streptozotocyn injection 
makes partial destruction of islet cell of pancreatic organ. 
This condition triggers relative hyperinsulinemia, high blood 
glucose and hyperlipidemia just like T2DM. Hyperlipidemia 
induces oxidative stress condition and inflammation, which 
induce alteration of GLUT-4 formation and function. Insulin 
resistant then disruptes peripheral glucose utilization.(9)
 Current researches indicate that T2DM’s effect is 
able to be reduced by herbals supplementation. In this 
research, the used herbal, Artemisia annua leaf extract, was 
significantly reduced high glucose levels. It is supported with 
previous research which proved that there was a reduction of 
FBG level in alloxan-induced rats that were given 28.5 mg/
kgBW  of Artemisia annua twice per day for 2 weeks. It also 
increased the insulin production and decreased homeostasis 
of model assessment for insulin resistance (HOMA-IR).(7) 
The purified extract of 83.56 mg/kg BW Artemisia annua 
was better in lowering FBG.(8)
 Although some studies confirmed about the antidiabetic 
potency of Artemisia annua, there is still no information 
available related to expression of GLUT-4 in muscle tissue. 
During insulin signaling, when insulin attaches to receptor 
dimer, the receptor experiences auto phosphorylation which 
is recognized by PKC. This phosphorylated form is called 
IRS. The IRS then recruits phosphatidil inositol kinase 3 
(PI3K) that bind to Protein kinase B (Akt)  molecules as its 
downstream signaling. PI3K/Akt is the pathways that been 
known to regulates GLUT-4 expression.(15) 
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Figure 3. Muscle GLUT-4 expression in muscle cells. GLUT-4 protein expressed at muscle cell membran and cytoplasmic as brown 
coloured. Intensed colour indicated more GLUT-4 expression. C1: (Average Allred: 4.6), arrows indicated strong intensity and percentage 
of cells expressing as much as 30%; C2: (Average Allred: 2.32), arrows indicated weak intensity with percentage of cells expressing GLUT-
4 by 20%;  T1: (Average Allred: 3.72), arrows indicated strong intensity and percentage of expressing cells as much as 20%; T2: (Average 
Allred: 4.8), arrows showed moderate intensity with the percentage of cells that express GLUT-4 as much as 60%. Muscle cell in passage 
observed with light microscope. White bar: 100µm.
 Beside via insulin signaling pathways, GLUT-
4 expression might also regulated by adenosine 
monophosphate-activated protein kinase (AMPK). Muscle 
activity and muscle volume influence AMPK activity that 
favor the GLUT-4 translocation.(16) GLUT-4 expression  is 
also influenced by acute or chronic changes of osmolarity 
and physical stress. Acute stress increases GLUT-4 
expression temporary, while chronic stress decreases 
GLUT-4 expression.(17)
 Glycolipotoxicity occur in diabetic condition (C2 
group). Glycolypotoxicity causes oxidative stress and 
inflammation that alters the phosphorylation of the IRS. 
Instead of phosphorylated by tyrosine, IRS become a 
subject of serine-threonine phosphorylation. This molecule 
deregulate PI3K downstream signaling and the ability 
to translocate GLUT-4. In  T2DM,  90%  insulin signal 
which promotes GLUT-4 translocation was diminished. 
On the other hand, AMPK only contributed to 30% of 
GLUT-4 translocation. This leads to the decline of GLUT-4 
expression under T2DM state.(14,18)
 In our studies, the administration of 100 mg /kg 
BW of Artemisia annua leaf extract at dose (T2 group) 
improved GLUT-4 expression. Artemisia annua contains 
phenolic flavonoid derivatives compound which may 
increase peripheral glucose influx. Some flavonoid 
derivates potentially increase glucose utilization by several 
mechanism, for example epigallocathein gallate (ECGC) 
increased insulin action via glucose utilization. The other 
compounds, kaemfetrin increased GLUT-4 translocation 
and synthesis in adipose cell and tissue. Quercertin, a 
flavonoid, increased the expression of GLUT-4 mRNAs 
and its translocation. ECGC, hisperidin and nangerin also 
increase GLUT-4 translocation in muscle and adipose cell 
membranes. Flavonoids derivates promote GLUT-4 muscle 
translation  from  PI3K  pathway.  In  addition,  flavonoids 
also activate  GLUT-4  translocation  through  AMPK 
pathway.(6)
 Other study stated that ethanol extract of Artemisia 
princeps increases glucose uptake by mediating GLUT-
4 translocation in myocite cell line.(19) Ethanolic extract 
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of  Artemisia  dracunculus L  enhance  insulin  receptor 
signaling, but not increase gen signaling of IRS-1, PI3K and 
GLUT-4 tanslocation. This condition  due to proteosome 
degradation and ubiquitin conjugation which reduce gene 
expression.(20) 
 However, it is better to figure out the successfulness 
of its therapy. Since the research itself is unable to detect 
the HbA1C changes due to the difference during treatment 
length (14 days), compared to the Wistar rat erythrocytes 
age (59 days). Glycemic reactions in HbA1C measurement 
occur in the 1st month of the end of the erythrocyte life 
cycle.(21) About 50% HbA1C levels reflect blood glucose 
levels in the last 30 days of erythrocyte life cycle. About 
25% HbA1C levels reflect the first 60-day blood sugar level 
of the erythrocyte life cycle. HbA1C reflects erythrocyte 
glycation for 117 days in men and 106 days in women.
(22) The study will be better if long term glucose control 
parameter use glicated albumin. This parameter reflects 
glucose control for approximately three weeks.(23) 
 More efficient extraction technique is needed in 
this studies to improve the artemisinin content in the 
extract. Infuse might be potential. It is developed from 9 
grams of dried leaves which result in 94 mg artemisinin. 
In term of pharmacokinetics standpoint, artemisin plasma 
concentration is 3.36 nm/mL with the half-life about 
2.4 hours. After 8 hours, the level of artemisinin will be 
eliminated. With this ratio, to achieve optimal plasma 
levels, the extract should be administrated more than once a 
day.(24) 
 The active compound in the Artemisia annua 
extract that poses an action to reduced blood glucose is 
unknown. But, Artemisia annua is one of the plants that 
contain high levels of flavonoids. Flavonoids generally 
have antidiabetic activity in the form of revitalization  and 
stimulation of pancreatic β cells in the release of insulin, 
increasing the sensitivity of insulin receptors or insulin 
like peptide, preventing glycogen breakdown, increasing 
glucose utilization at peripheral tissue, promote free radical 
clearance, and improve microcirculation.(25)
 Besides that, the extract contains artemisinin, 
polyphenols, flavonoids, vitamins C and E which are 
antioxidants.(26) Flavonoids in the extract has an 
antioxidant effect. Antioxidants will prevent oxidative stress 
so it will prevent pancreatic β cell death, thus improving 
insulin secretion. Decreased oxidative stress will also 
improve insulin action in peripheral glucose utilization 
and prevent glycogenolisis from the liver. When insulin 
actions appropriate, fasting blood sugar and postprandial 
blood sugar will be well controlled. Glucose levels will 
be maintained within the normal range which will further 
decrease  glycemic  erythrocytes  emitted  from  HbA1C 
levels.(27)   
 A study of 38,018 women which at risk of T2DM, 
differences dietary flavonoid consumption patterns in 8-year-
old observations, was associated with a decrease in the risk 
of T2DM. The difference in the amount of consumption 
of flavonoid was not significantly associated with HbA1C 
decline, fasting insulin concentration, interleukin-6 (IL-6) 
and C-ractive protein (CRP). These results are possible due 
to differences in group characteristics. Each group has a 
habit of smoking, alcohol, exercise, diet, fat-carbohydrate 
intake, blood glucose fluctuation and  history of other 
diseases of different metabolic syndrome.(28)   
 This study proves that giving Artemisia annua leaf 
extract to T2DM rats improves muscle GLUT-4 expression 
and slightly lowers HbA1C as the goal of long term glycemic 
control in DM.
         There are some limitations of this study. Total 
flavonoid content for dose standardization has not been 
measured. Determination of doses in this study only based 
on previous research. Lenght of  treatment is also  too 
short,  about 14 days, whereas HbA1C is a parameter of 
controlling long-term  blood sugar levels whose value 
corresponds to Wistar erythrocyte age about 59 days. This 
study also has not measured the factors of kidney damage, 
liver and possible anemia in rats that are likely to affect the 
interpretation of HbA1C measurements.(25) 
        Further research are still needed to find out the 
active flavonoid content to standard the dosage. Research 
should measure the effect of the various levels of dosage. 
Research on acute, sub-chronic and chronic toxicity is also 
required for the development of Artemisia annua research 
as an herbal remedy for T2DM. More research using better 
parameter of long term blood glucose control using more 
preferable variabel.
Conclusion
Muscle cell’s GLUT-4 in T1 and T2 group was expressed 
increasingly and significantly different compared to C2 
group. HbA1C level in T2 group was slightly reduced 
although there was found no significant different compared 
to diabetic control.
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